Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Meconium Aspiration Syndrome
NCT05517499Completed
- Sponsor
- Services Institute of Medical Sciences
- Start
- Jan 2021
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of dexamethasone in Meconium aspiration syndrome (MAS) (2 arms), sponsored by Services Institute of Medical Sciences. Primary endpoints: Number of days required for ventilation at 7 days, Number of days required for oxygen therapy at 7 days and 1 more. Started Jan 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
Meconium aspiration syndrome (MAS)
Beyond the preview
Go deeper on NCT05517499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05517499.